Screener
Apogee Therapeutics, Inc. APGE PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | MARCH 31,2026 | DECEMBER 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 13,912 | 11,166 |
| Total current assets | 1,073,797 | 741,358 |
| Long-term marketable securities | 198,354 | 172,730 |
| Property and equipment, net | 5,280 | 5,688 |
| Right-of-use asset, net | 7,707 | 8,687 |
| Other non-current assets | 8,516 | 8,671 |
| Total assets | $1,293,654 | $937,134 |
| Liabilities and stockholders' equity |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s PP&E (net)?
- Apogee Therapeutics, Inc. (APGE) reported PP&E (net) of $5.28M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Apogee Therapeutics, Inc.'s PP&E (net) decreased by 7.0% year-over-year, from $5.68M to $5.28M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s PP&E (net) has grown at a 288.4% compound annual growth rate (CAGR), from $377K to $5.69M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Apogee Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude